A detailed history of Cornercap Investment Counsel Inc transactions in Alector, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 11,767 shares of ALEC stock, worth $30,241. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,767
Previous 24,319 51.61%
Holding current value
$30,241
Previous $110,000 50.91%
% of portfolio
0.02%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$4.34 - $6.58 $54,475 - $82,592
-12,552 Reduced 51.61%
11,767 $54,000
Q2 2024

Aug 08, 2024

SELL
$4.19 - $6.23 $892 - $1,326
-213 Reduced 0.87%
24,319 $110,000
Q3 2023

Nov 13, 2023

BUY
$5.2 - $8.77 $1,674 - $2,823
322 Added 1.33%
24,532 $158,000
Q2 2023

Aug 11, 2023

BUY
$5.86 - $7.93 $3,041 - $4,115
519 Added 2.19%
24,210 $145,000
Q1 2023

May 11, 2023

BUY
$5.85 - $9.84 $5,926 - $9,967
1,013 Added 4.47%
23,691 $146,000
Q4 2022

Feb 13, 2023

BUY
$6.88 - $9.55 $12,459 - $17,295
1,811 Added 8.68%
22,678 $209,000
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $56,953 - $91,792
6,954 Added 49.98%
20,867 $197,000
Q2 2022

Aug 15, 2022

BUY
$7.65 - $14.24 $106,434 - $198,121
13,913 New
13,913 $141,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $212M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.